Advertisement
Search for

Volume 7, Issue 8, Pages 906-909 (August 2009)


View previous. 28 of 38 View next.

Additional Online Content AvailableRisk of Complications After Abdominal Paracentesis in Cirrhotic Patients: A Prospective Study

Andrea De GottardiCorresponding Author Informationemail address, Thierry Thévenot, Laurent Spahr, Isabelle Morard, Solange Bresson–Hadni, Ferran Torres§, Emiliano Giostra, Antoine Hadengue

published online 18 May 2009.

Background & Aims

Complications and technical problems of paracentesis in cirrhotic patients are infrequent. However, the severity and the incidence of these events and their risk factors have not been assessed prospectively.

Methods

Cirrhotic patients (n = 171) undergoing paracentesis were included. Of the 515 paracenteses, 8.8% were diagnostic, and 91.2% were therapeutic. Technical features, demographic data, and adverse events during a period of 72 hours after the procedure were examined.

Results

Major complications occurred in 1.6% of procedures and included 5 bleedings and 3 infections, resulting in death in 2 cases. Major complications were associated with therapeutic but not diagnostic procedures and tended to be more prevalent in patients with low platelet count (<50 109/L), Child-Pugh stage C, and in alcoholic cirrhosis patients. Technical problems occurred in 5.6%. The most frequent complication was a leak of ascites at the puncture site (5.0%), and in 89.5% there were no complications.

Conclusions

The safety of paracentesis in cirrhotic patients might be decreased if risk factors, which depend on the characteristics of the patient and of the procedure itself, are present.

 Division of Gastroenterology and Hepatology, University Hospital of Geneva, Geneva, Switzerland

 Division of Hepatology, Hôpital Jean Minjoz, Besançon, France

§ Laboratory of Biostatistics and Epidemiology (Universitat Autònoma de Barcelona) and Clinical Pharmacology (Hospital Clínic), Barcelona, Spain

Corresponding Author InformationReprint requests Address requests for reprints to: Dr Andrea De Gottardi, Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Clínic, Villarroel 170, 08036 Barcelona, Spain. fax: (34) 93-227-93-48

 Conflicts of interest The authors disclose no conflicts.

 Funding A.D.G. is supported by a Sheila Sherlock Fellowship from the European Association for the Study of the Liver and by the Swiss Foundation for Grants in Biology and Medicine.

PII: S1542-3565(09)00438-8

doi:10.1016/j.cgh.2009.05.004


View previous. 28 of 38 View next.

Advertisement